Targeting Vitamin-D receptor (VDR) by a small molecule antagonist MeTC7 inhibits PD-L1 but controls THMYCN neuroblastoma growth PD-L1 independently
Rakesh K. Singh(University of Rochester Medical Center), Richard G. Moore(University of Rochester Medical Center)
Cited by 4
Related Papers
CXCR1 and CXCR2 enhances human melanoma tumourigenesis, growth and invasion
|British Journal of Cancer|2009|127
Tetrathiomolybdate inhibits mitochondrial complex IV and mediates degradation of hypoxia-inducible factor-1α in cancer cells
|Scientific Reports|2015|62
Tetrathiomolybdate sensitizes ovarian cancer cells to anticancer drugs doxorubicin, fenretinide, 5-fluorouracil and mitomycin C
|BMC Cancer|2012|40
Role of trypsin and protease-activated receptor-2 in ovarian cancer
|PLoS ONE|2020|40